CollPlant Biotechnologies (CLGN) Q2 2024 Earnings
CLGN·Reported August 20, 2024·Before market open
CollPlant Biotechnologies reported Q2 2024 revenue of $249.0K, missed analyst consensus of $420.0K by $171.0K. Diluted EPS came in at $-0.37, missed the $-0.35 consensus by $0.02.
Revenue
$249.0Kmissed by $171.0K
Consensus: $420.0KDiluted EPS
$-0.37missed by $0.02
Consensus: $-0.35
SEC Filings
Earnings release8-K not filed yet
Quarterly report10-Q / 10-K not filed yet
Filings will appear here once submitted to SEC EDGAR.
Q2 2024 Earnings FAQ
Common questions about CollPlant Biotechnologies's Q2 2024 earnings report.
CollPlant Biotechnologies (CLGN) reported Q2 2024 earnings on August 20, 2024 before market open.
CollPlant Biotechnologies reported revenue of $249.0K and diluted EPS of $-0.37 for Q2 2024.
Revenue missed the consensus estimate of $420.0K by $171.0K. EPS missed the consensus estimate of $-0.35 by $0.02.